These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 32746933)
1. Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes. Shibamura M; Yoshikawa T; Yamada S; Inagaki T; Nguyen PHA; Fujii H; Harada S; Fukushi S; Oka A; Mizuguchi M; Saijo M Virol J; 2020 Aug; 17(1):120. PubMed ID: 32746933 [TBL] [Abstract][Full Text] [Related]
2. Neutralizing and ELISA IgG antibodies to human cytomegalovirus glycoprotein complexes may help date the onset of primary infection in pregnancy. Lilleri D; Gerna G; Furione M; Zavattoni M; Spinillo A J Clin Virol; 2016 Aug; 81():16-24. PubMed ID: 27289427 [TBL] [Abstract][Full Text] [Related]
3. Dense Bodies of a gH/gL/UL128/UL130/UL131 Pentamer-Repaired Towne Strain of Human Cytomegalovirus Induce an Enhanced Neutralizing Antibody Response. Lehmann C; Falk JJ; Büscher N; Penner I; Zimmermann C; Gogesch P; Sinzger C; Plachter B J Virol; 2019 Sep; 93(17):. PubMed ID: 31189713 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation. Gerna G; Percivalle E; Perez L; Lanzavecchia A; Lilleri D J Virol; 2016 Jul; 90(14):6216-6223. PubMed ID: 27122579 [TBL] [Abstract][Full Text] [Related]
5. Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex. Wussow F; Chiuppesi F; Martinez J; Campo J; Johnson E; Flechsig C; Newell M; Tran E; Ortiz J; La Rosa C; Herrmann A; Longmate J; Chakraborty R; Barry PA; Diamond DJ PLoS Pathog; 2014 Nov; 10(11):e1004524. PubMed ID: 25412505 [TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in Human Cytomegalovirus Glycoprotein O (gO) Exert Epistatic Influences on Cell-Free and Cell-to-Cell Spread and Antibody Neutralization on gH Epitopes. Day LZ; Stegmann C; Schultz EP; Lanchy JM; Yu Q; Ryckman BJ J Virol; 2020 Mar; 94(8):. PubMed ID: 31996433 [TBL] [Abstract][Full Text] [Related]
8. Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection. Chiuppesi F; Wussow F; Johnson E; Bian C; Zhuo M; Rajakumar A; Barry PA; Britt WJ; Chakraborty R; Diamond DJ J Virol; 2015 Dec; 89(23):11884-98. PubMed ID: 26378171 [TBL] [Abstract][Full Text] [Related]
9. A Novel Strain-Specific Neutralizing Epitope on Glycoprotein H of Human Cytomegalovirus. Thomas M; Kropff B; Schneider A; Winkler TH; Görzer I; Sticht H; Britt WJ; Mach M; Reuter N J Virol; 2021 Aug; 95(18):e0065721. PubMed ID: 34160252 [TBL] [Abstract][Full Text] [Related]
10. Strain-specific neutralizing antibody responses against human cytomegalovirus envelope glycoprotein N. Pati SK; Novak Z; Purser M; Arora N; Mach M; Britt WJ; Boppana SB Clin Vaccine Immunol; 2012 Jun; 19(6):909-13. PubMed ID: 22492744 [TBL] [Abstract][Full Text] [Related]
11. Immunization of Rabbits with Recombinant Human Cytomegalovirus Trimeric versus Monomeric gH/gL Protein Elicits Markedly Higher Titers of Antibody and Neutralization Activity. Cui X; Cao Z; Wang S; Flora M; Adler SP; McVoy MA; Snapper CM Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261659 [TBL] [Abstract][Full Text] [Related]
12. Primary human cytomegalovirus infections: kinetics of ELISA-IgG and neutralizing antibody in pauci/asymptomatic pregnant women vs symptomatic non-pregnant subjects. Fornara C; Furione M; Lilleri D; Cane I; Revello MG; Zavattoni M; Gerna G J Clin Virol; 2015 Mar; 64():45-51. PubMed ID: 25728078 [TBL] [Abstract][Full Text] [Related]
13. Serum antibody response to the gH/gL/pUL128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections. Genini E; Percivalle E; Sarasini A; Revello MG; Baldanti F; Gerna G J Clin Virol; 2011 Oct; 52(2):113-8. PubMed ID: 21820353 [TBL] [Abstract][Full Text] [Related]
14. Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex. Ha S; Li F; Troutman MC; Freed DC; Tang A; Loughney JW; Wang D; Wang IM; Vlasak J; Nickle DC; Rustandi RR; Hamm M; DePhillips PA; Zhang N; McLellan JS; Zhu H; Adler SP; McVoy MA; An Z; Fu TM J Virol; 2017 Apr; 91(7):. PubMed ID: 28077654 [TBL] [Abstract][Full Text] [Related]
15. Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex. Macagno A; Bernasconi NL; Vanzetta F; Dander E; Sarasini A; Revello MG; Gerna G; Sallusto F; Lanzavecchia A J Virol; 2010 Jan; 84(2):1005-13. PubMed ID: 19889756 [TBL] [Abstract][Full Text] [Related]
16. Glycoprotein N of human cytomegalovirus protects the virus from neutralizing antibodies. Kropff B; Burkhardt C; Schott J; Nentwich J; Fisch T; Britt W; Mach M PLoS Pathog; 2012; 8(10):e1002999. PubMed ID: 23133379 [TBL] [Abstract][Full Text] [Related]
17. Human Cytomegalovirus gH/gL/gO Promotes the Fusion Step of Entry into All Cell Types, whereas gH/gL/UL128-131 Broadens Virus Tropism through a Distinct Mechanism. Zhou M; Lanchy JM; Ryckman BJ J Virol; 2015 Sep; 89(17):8999-9009. PubMed ID: 26085146 [TBL] [Abstract][Full Text] [Related]
18. Human cytomegalovirus infection elicits a glycoprotein M (gM)/gN-specific virus-neutralizing antibody response. Shimamura M; Mach M; Britt WJ J Virol; 2006 May; 80(9):4591-600. PubMed ID: 16611919 [TBL] [Abstract][Full Text] [Related]
19. Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infection. Lilleri D; Kabanova A; Revello MG; Percivalle E; Sarasini A; Genini E; Sallusto F; Lanzavecchia A; Corti D; Gerna G PLoS One; 2013; 8(3):e59863. PubMed ID: 23555812 [TBL] [Abstract][Full Text] [Related]
20. Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies. Loomis RJ; Lilja AE; Monroe J; Balabanis KA; Brito LA; Palladino G; Franti M; Mandl CW; Barnett SW; Mason PW Vaccine; 2013 Jan; 31(6):919-26. PubMed ID: 23246547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]